PMID- 2468163 OWN - NLM STAT- MEDLINE DCOM- 19890524 LR - 20190501 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 86 IP - 8 DP - 1989 Apr TI - cAMP and forskolin decrease gamma-aminobutyric acid-gated chloride flux in rat brain synaptoneurosomes. PG - 2938-42 AB - The effects of the cyclic nucleotide cAMP on gamma-aminobutyric acid-gated chloride channel function were investigated. The membrane-permeant cAMP analog N6,O2'-dibutyryladenosine 3',5'-cyclic monophosphate inhibited muscimol-induced 36Cl- uptake into rat cerebral cortical synaptoneurosomes in a concentration-dependent manner (IC50 = 1.3 mM). The inhibition was due to a decrease in the maximal effect of muscimol, with no change in potency. Similar effects were observed with 8-(4-chlorophenylthio)adenosine 3',5'-cyclic monophosphate, 8-bromoadenosine 3',5'-cyclic monophosphate, and the phosphodiesterase inhibitor isobutylmethylxanthine. The effect of endogenous cAMP accumulation on the gamma-aminobutyric acid-gated Cl- channel was studied with forskolin, an activator of adenylate cyclase. Under identical conditions, in the intact synaptoneurosomes, forskolin inhibited muscimol-induced 36Cl- uptake and generated cAMP with similar potencies (IC50 = 14.3 microM; EC50 = 6.2 microM, respectively). Surprisingly, 1,9-dideoxyforskolin, which does not activate adenylate cyclase, also inhibited the muscimol response, suggesting that forskolin and its lipophilic derivatives may interact with the Cl- channel directly. Indeed, forskolin inhibition of muscimol-induced 36Cl- uptake was extremely rapid (within 5 sec), preceding the accumulation of sufficient levels of cAMP. After 5 min, a slower phase of inhibition was seen, similar to the time course for cAMP accumulation. The data suggest that gamma-aminobutyric acid (GABAA) receptor function in brain can be regulated by cAMP-dependent phosphorylation. FAU - Heuschneider, G AU - Heuschneider G AD - Department of Pharmacology, Duke University Medical Center, Durham, NC 27710. FAU - Schwartz, R D AU - Schwartz RD LA - eng GR - NS 24577/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Chloride Channels) RN - 0 (Chlorides) RN - 0 (Membrane Proteins) RN - 1F7A44V6OU (Colforsin) RN - 2763-96-4 (Muscimol) RN - 56-12-2 (gamma-Aminobutyric Acid) RN - 63X7MBT2LQ (Bucladesine) RN - E0399OZS9N (Cyclic AMP) RN - TBT296U68M (1-Methyl-3-isobutylxanthine) SB - IM MH - 1-Methyl-3-isobutylxanthine/pharmacology MH - Animals MH - Brain/*physiology MH - Bucladesine/pharmacology MH - Chloride Channels MH - Chlorides/*physiology MH - Colforsin/*pharmacology MH - Cyclic AMP/*physiology MH - In Vitro Techniques MH - Membrane Proteins/*physiology MH - Muscimol/pharmacology MH - Rats MH - Synaptosomes MH - gamma-Aminobutyric Acid/*physiology PMC - PMC287035 EDAT- 1989/04/01 00:00 MHDA- 1989/04/01 00:01 PMCR- 1989/10/01 CRDT- 1989/04/01 00:00 PHST- 1989/04/01 00:00 [pubmed] PHST- 1989/04/01 00:01 [medline] PHST- 1989/04/01 00:00 [entrez] PHST- 1989/10/01 00:00 [pmc-release] AID - 10.1073/pnas.86.8.2938 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 1989 Apr;86(8):2938-42. doi: 10.1073/pnas.86.8.2938.